Pyrimethamine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pyrimethamine and what is the scope of freedom to operate?
Pyrimethamine
is the generic ingredient in three branded drugs marketed by Tilde Sciences, Alvogen, Aurobindo Pharma Ltd, Sanaluz, Teva Pharms, and Roche, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for pyrimethamine. Eight suppliers are listed for this compound.
Summary for pyrimethamine
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 6 |
NDAs: | 6 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 128 |
Clinical Trials: | 222 |
Patent Applications: | 6,762 |
Drug Prices: | Drug price trends for pyrimethamine |
What excipients (inactive ingredients) are in pyrimethamine? | pyrimethamine excipients list |
DailyMed Link: | pyrimethamine at DailyMed |
Recent Clinical Trials for pyrimethamine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kamuzu University of Health Sciences | Phase 4 |
Malaria Consortium | Phase 3 |
Washington University School of Medicine | Early Phase 1 |
Pharmacology for pyrimethamine
Drug Class | Dihydrofolate Reductase Inhibitor Antimalarial |
Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for pyrimethamine
Anatomical Therapeutic Chemical (ATC) Classes for pyrimethamine
US Patents and Regulatory Information for pyrimethamine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tilde Sciences | DARAPRIM | pyrimethamine | TABLET;ORAL | 008578-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 215506-001 | Aug 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Ltd | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 216983-001 | Oct 25, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sanaluz | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 207127-001 | Feb 28, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.